🔎 Trials Near Me

መነሻ › ትሪፕል-ኔጌቲቭ የደረት ካንሰር › አላባማ

በአላባማ ለትሪፕል-ኔጌቲቭ የደረት ካንሰር የሚደረጉ ክሊኒካዊ ጥናቶች

ለትሪፕል-ኔጌቲቭ የደረት ካንሰር የሚደረጉ 11 ጥናቶች በአላባማ ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።

በአላባማ ውስጥ ያሉ ከተሞች

Official study text (English)

177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors

  • Dothan Hematology & Oncology, Dothan
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT07189871

PRE-ISPY Phase I/II Oncology Platform Program

  • The University of Alabama at Birmingham O'Neal Comprehensive Cancer Center, Birmingham
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ30 ሴፕቴ 2026 · NCT05868226

A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)

  • USA Mitchell Cancer Institute ( Site 0090), Mobile
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT06841354

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

  • Infirmary Cancer Care ( Site 0001), Mobile
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT06393374

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

  • University of Alabama at Birmingham, Birmingham
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ23 ሴፕቴ 2026 · NCT06618287

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

  • Alabama Oncology, Birmingham
  • Clearview Cancer Institute, Huntsville
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ9 ሴፕቴ 2026 · NCT05633654

Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies

  • Birmingham Hematology Associates, Birmingham
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ ከ18 እስከ 99 · ሁሉም ጾታዎች · የተሻሻለው በ3 ሴፕቴ 2026 · NCT07211178

Monitoring Breast Cancer Immunotherapy Treatment With Advanced Positron Emission Tomography Magnetic Resonance Imaging (PET/MRI)

  • UAB, Birmingham
ተሳታዮችን በመፈለግ ላይየመጀመሪያ ደረጃ 1
እድሜ ከ18 እስከ 75 · ሴቶች · የተሻሻለው በ17 ኦገስ 2026 · NCT04861077

Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers

  • Uni of Alabama at Birmingham, Birmingham
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ ከ18 እስከ 100 · ሁሉም ጾታዎች · የተሻሻለው በ29 ጁላይ 2026 · NCT06562192

A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

  • University of Alabama at Birmingham, Birmingham
  • University of Alabama at Birmingham, IDS Pharmacy, Birmingham
  • University of Alabama at Birmingham, Birmingham
  • እና 1 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ጁላይ 2026 · NCT05208762

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

  • University of Alabama at Birmingham, Birmingham
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ6 ሜይ 2026 · NCT01042379

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።